• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production.脂肪酸合酶通过抑制 TNF-α 和神经酰胺的产生引起耐药性。
J Lipid Res. 2013 Mar;54(3):776-785. doi: 10.1194/jlr.M033811. Epub 2013 Jan 14.
2
A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction.乳腺癌细胞耐药的一种新机制:脂肪酸合酶过表达介导的棕榈酸过度产生。
Mol Cancer Ther. 2008 Feb;7(2):263-70. doi: 10.1158/1535-7163.MCT-07-0445.
3
Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype.脂肪酸合酶抑制剂奥利司他对T细胞淋巴瘤的肿瘤生长抑制及化疗增敏作用:重构肿瘤微环境和多药耐药表型的影响
Biochim Biophys Acta. 2014 Jan;1840(1):294-302. doi: 10.1016/j.bbagen.2013.09.020. Epub 2013 Sep 20.
4
Molecular mechanisms of fatty acid synthase (FASN)-mediated resistance to anti-cancer treatments.脂肪酸合酶(FASN)介导的抗癌治疗耐药性的分子机制
Adv Biol Regul. 2014 Jan;54:214-21. doi: 10.1016/j.jbior.2013.09.004. Epub 2013 Sep 15.
5
Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes.淀粉样β肽通过中性鞘磷脂酶/神经酰胺途径增强少突胶质细胞中肿瘤坏死因子-α诱导的诱导型一氧化氮合酶。
J Neurochem. 2005 Aug;94(3):703-12. doi: 10.1111/j.1471-4159.2005.03217.x.
6
Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis.大黄素对脂肪酸合酶、结肠癌增殖和凋亡的抑制作用。
Mol Med Rep. 2017 Apr;15(4):2163-2173. doi: 10.3892/mmr.2017.6254. Epub 2017 Feb 28.
7
Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.C16-神经酰胺和1-磷酸鞘氨醇在调节肿瘤坏死因子-α诱导的肝细胞凋亡中的作用。
J Biol Chem. 2005 Jul 29;280(30):27879-87. doi: 10.1074/jbc.M503002200. Epub 2005 Jun 9.
8
Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer.脂肪酸合酶过表达:卵巢癌治疗及逆转化疗耐药性的靶点
J Transl Med. 2015 May 7;13:146. doi: 10.1186/s12967-015-0511-3.
9
Overexpression of fatty acid synthase in Middle Eastern epithelial ovarian carcinoma activates AKT and Its inhibition potentiates cisplatin-induced apoptosis.脂肪酸合酶在中东上皮性卵巢癌中的过表达激活 AKT,其抑制作用增强顺铂诱导的细胞凋亡。
Mol Med. 2011;17(7-8):635-45. doi: 10.2119/molmed.2011.00046. Epub 2011 Mar 21.
10
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells.脂肪酸合酶磷酸化:HER2 过表达乳腺癌细胞的一个新的治疗靶点。
Breast Cancer Res. 2010;12(6):R96. doi: 10.1186/bcr2777. Epub 2010 Nov 16.

引用本文的文献

1
Integrated prognostic assessment of apoptosis and chemotherapy related gene in bladder cancer: a prognostic signature.膀胱癌中凋亡与化疗相关基因的综合预后评估:一种预后标志物
Discov Oncol. 2025 May 10;16(1):718. doi: 10.1007/s12672-025-02581-5.
2
LC-MS analysis of serum lipidomic and metabolomic signatures in pediatric patients with acute lymphoblastic leukemia.急性淋巴细胞白血病患儿血清脂质组学和代谢组学特征的液相色谱-质谱分析
Ital J Pediatr. 2025 Mar 12;51(1):74. doi: 10.1186/s13052-025-01921-z.
3
Clinical significance of lipid pathway-targeted therapy in breast cancer.脂质途径靶向治疗在乳腺癌中的临床意义。
Front Pharmacol. 2025 Jan 6;15:1514811. doi: 10.3389/fphar.2024.1514811. eCollection 2024.
4
Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets.脑胶质瘤中代谢重编程:通路与治疗靶点综述。
Cells. 2024 Sep 19;13(18):1574. doi: 10.3390/cells13181574.
5
Identification of potential tissue-specific biomarkers involved in pig fat deposition through integrated bioinformatics analysis and machine learning.通过综合生物信息学分析和机器学习识别参与猪脂肪沉积的潜在组织特异性生物标志物。
Heliyon. 2024 May 15;10(10):e31311. doi: 10.1016/j.heliyon.2024.e31311. eCollection 2024 May 30.
6
Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA.乳腺癌化疗耐药性:lncRNA 调控作用的新见解。
Int J Mol Sci. 2023 Nov 2;24(21):15897. doi: 10.3390/ijms242115897.
7
Radiation-induced gastric injury during radiotherapy: molecular mechanisms and clinical treatment.放疗期间的放射性胃损伤:分子机制和临床治疗。
J Radiat Res. 2023 Nov 21;64(6):870-879. doi: 10.1093/jrr/rrad071.
8
Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy.针对癌症代谢途径以改善化疗和免疫疗法。
Cancer Lett. 2023 Oct 28;575:216396. doi: 10.1016/j.canlet.2023.216396. Epub 2023 Sep 20.
9
Protective Effect of Triclosan in Monocrotaline-Induced Pulmonary Arterial Hypertension: FASN Inhibition a Novel Approach.三氯生对野百合碱诱导的肺动脉高压的保护作用:抑制脂肪酸合酶是一种新方法。
J Pharm Bioallied Sci. 2022 Oct-Dec;14(4):171-177. doi: 10.4103/jpbs.jpbs_307_22. Epub 2023 Feb 17.
10
Novel Insights on Lipid Metabolism Alterations in Drug Resistance in Cancer.癌症耐药中脂质代谢改变的新见解
Front Cell Dev Biol. 2022 May 13;10:875318. doi: 10.3389/fcell.2022.875318. eCollection 2022.

本文引用的文献

1
Hallmarks of cancer: the next generation.癌症的特征:下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
2
Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers.脂肪酸合酶在胰腺癌吉西他滨耐药及放射抵抗中的作用
Int J Biochem Mol Biol. 2011 Jan 1;2(1):89-98.
3
Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-α in MCF-7 cells.中性鞘磷脂酶 2(nSMase2)是 MCF-7 细胞中肿瘤坏死因子-α激活的主要中性鞘磷脂酶同工酶。
Biochem J. 2011 Apr 15;435(2):381-90. doi: 10.1042/BJ20101752.
4
The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer.乳腺癌中的磷脂酰肌醇 3-激酶/AKT 信号通路。
Cancer Metastasis Rev. 2010 Dec;29(4):751-9. doi: 10.1007/s10555-010-9261-0.
5
Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker.脂肪酸合酶的生物化学、分子生物学及药理学:一个新兴的治疗靶点与诊断/预后标志物
Int J Biochem Mol Biol. 2010 Jul 18;1(1):69-89.
6
Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.哺乳动物中性鞘磷脂酶:调节和在细胞信号转导反应中的作用。
Neuromolecular Med. 2010 Dec;12(4):320-30. doi: 10.1007/s12017-010-8120-z. Epub 2010 Jun 16.
7
Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.泛素特异性蛋白酶 8 将 PTEN-Akt-AIP4 通路与多形性胶质母细胞瘤中 FLIPS 稳定性和 TRAIL 敏感性的控制联系起来。
Cancer Res. 2010 Jun 15;70(12):5046-53. doi: 10.1158/0008-5472.CAN-09-3979. Epub 2010 May 18.
8
A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.一种新的依赖于PTEN的与泛素化的联系控制多形性胶质母细胞瘤中FLIPS的稳定性和TRAIL敏感性。
Cancer Res. 2009 Oct 15;69(20):7911-6. doi: 10.1158/0008-5472.CAN-09-1287. Epub 2009 Oct 6.
9
Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin.抗癌药物柔红霉素诱导人乳腺癌细胞系MCF-7中性鞘磷脂酶2基因表达的转录调控
Biochim Biophys Acta. 2009 Nov-Dec;1789(11-12):681-90. doi: 10.1016/j.bbagrm.2009.08.006. Epub 2009 Aug 19.
10
Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors.肿瘤坏死因子-α诱导的中性鞘磷脂酶-2通过控制N-甲基-D-天冬氨酸受体的膜插入来调节突触可塑性。
J Neurochem. 2009 Jun;109(5):1237-49. doi: 10.1111/j.1471-4159.2009.06038.x. Epub 2009 Mar 14.

脂肪酸合酶通过抑制 TNF-α 和神经酰胺的产生引起耐药性。

Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production.

机构信息

Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN.

Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN.

出版信息

J Lipid Res. 2013 Mar;54(3):776-785. doi: 10.1194/jlr.M033811. Epub 2013 Jan 14.

DOI:10.1194/jlr.M033811
PMID:23319743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3617951/
Abstract

Fatty acid synthase (FASN) is a key enzyme in the synthesis of palmitate, the precursor of major nutritional, energetic, and signaling lipids. FASN expression is upregulated in many human cancers and appears to be important for cancer cell survival. Overexpression of FASN has also been found to associate with poor prognosis and higher risk of recurrence of human cancers. Indeed, elevated FASN expression has been shown to contribute to drug resistance. However, the mechanism of FASN-mediated drug resistance is currently unknown. In this study, we show that FASN overexpression causes resistance to multiple anticancer drugs via inhibiting drug-induced ceramide production, caspase 8 activation, and apoptosis. We also show that FASN overexpression suppresses tumor necrosis factor-α production and nuclear factor-κB activation as well as drug-induced activation of neutral sphingomyelinase. Thus, TNF-α may play an important role in mediating FASN function in drug resistance.

摘要

脂肪酸合酶(FASN)是合成棕榈酸的关键酶,棕榈酸是主要营养物质、能量物质和信号脂质的前体。在许多人类癌症中,FASN 的表达上调,并且似乎对癌细胞存活很重要。FASN 的过表达也与人类癌症的预后不良和复发风险增加有关。事实上,已经表明升高的 FASN 表达有助于耐药性。然而,目前尚不清楚 FASN 介导的耐药性的机制。在这项研究中,我们表明 FASN 的过表达通过抑制药物诱导的神经酰胺产生、半胱天冬酶 8 的激活和细胞凋亡导致对多种抗癌药物的耐药性。我们还表明,FASN 的过表达抑制肿瘤坏死因子-α的产生和核因子-κB 的激活以及药物诱导的中性鞘磷脂酶的激活。因此,TNF-α可能在介导 FASN 功能中的药物耐药性方面发挥重要作用。